Want to join the conversation?
Adhesives manufacturer $FUL reported 2Q16 net income attributable to company of $33.3MM or $0.65 per diluted share, up 31.9% versus $25.3MM or $0.49 per diluted share in 2Q15, helped by lower cost of sales and lower income taxes. Net revenue fell 1.5% to $ 532.5MM, negatively impacted by lower ASPs and negative foreign currency translation.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.